Transcatheter Interventions Online

Don't miss this innovative educational event focused on novel interventional practice lead by Prof Nicolas Van Mieghem (Erasmus MC, Rotterdam, NL). Entirely digital over 3 days (see Full Agenda), and free to HCPs, it will include updated education and live cases for cardiologists, interventionalists and surgeons interested in transcatheter treatment strategies for coronary and structural heart disease.

CME Accreditation

This three-day programme has been accredited by the European Board for Accreditation in Cardiology (EBAC) for a total of 12 CME points, equating to 12 hours of learning (4 hours per day). Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://www.ama-assn.org/

You can view more detail on the faculty and programme, and watch on demand today:

Provisional Agenda (subject to change)

HIGHLIGHTS

• World-Class Faculty
• Live Case Transmissions
• Structural Heart Disease
• Complex PCI (CHIP)
• Novel Technologies
• Latest Clinical Data Analysis

PARTNERS

This programme is supported by unrestricted educational grants from the following companies. The scientific programme has not been influenced in any way by the sponsors.

COURSE DIRECTOR

NICOLAS M VAN MIEGHEM

Medical Director

Prof Nicolas M. Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, USA and Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology in the Thoraxcenter, Erasmus University Medical Center as a senior staff member in February 2010. He became full professor of Interventional Cardiology September 1 2019.

He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored over 350 scientific papers in peer-reviewed journals.

Prof Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology (FESC), Fellow of the American College of Cardiology, Member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and is currently Medical Director of the department of Interventional Cardiology in the Thoraxcenter, Erasmus University Medical Center, Rotterdam.